Appendix Table 2.

Opioid-Prescribing Protocol Elements, Opioid Fill Information, and Co-Medications, for Patients with a BMI ≥30 kg/m2 with any Opioid Prescription in Pre- or Post-Intervention Period

Pre-Intervention (n = 1161)Post-Intervention (n = 963)P-Value
Protocol elements
    Urine drug screen202 (17.4%)251 (26.1%)<.0001
    ORT completedn/a60 (6.2%)n/a
    COMMn/a49 (5.1%)n/a
    Opioid treatment agreement125 (10.8%)127 (13.2%).086
No. elementsn/a
    0n/a680 (70.6%)
    1n/a169 (17.6%)
    ≥2n/a114 (11.8%)
No longer on opioid616 (53.1%)n/an/a
Still on opioid545 (46.9%)n/an/a
Opioid fill information
Total No. RX, mean (±SD)7.7 (±10.6)7.6 (±9.0).811
Total No. RX, categories
    1406 (35.0%)341 (35.4%)
    2176 (15.2%)118 (12.3%).274
    372 (6.2%)64 (6.6%)
    ≥4507 (43.7%)440 (45.7%)
Max daily dose (MED)*(n = 1158)(n = 958)
    1 to 50 mg1016 (87.7%)822 (85.8%)
    51 to 100 mg112 (9.7%)109 (11.4%).409
    >100 mg30 (2.6%)27 (2.8%)
Co-medications
    Tramadol265 (22.8%)182 (18.9%).027
    Benzodiazepines298 (25.7%)247 (25.7%).992
    Antidepressants685 (59.0%)534 (55.5%).100
    Musculoskeletal agents386 (33.3%)321 (33.3%).967
    Anticonvulsants310 (26.7%)287 (29.8%).113
  • COMM, current opioid misuse measure; MED, morphine equivalent dose; ORT, opioid risk tool; RX, prescription; SD, standard deviations; BMI, body mass index.

  • * Excludes methadone prescriptions.